Hematology TimesCHMP backs 2 biosimilar pegfilgrastim productsJuly 31, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Hematology NewsIsavuconazole resolved invasive fungal disease in patients on ibrutinibJuly 29, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersCLL
Hematology TimesGlobal burden of hematologic malignanciesJuly 29, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Oncology PracticeLate mortality risk after childhood BMT is substantial, persistentJuly 28, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaIndolent LymphomaMantle Cell Lymphoma
Hematology TimesDrug receives fast track designation for WMJuly 26, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsRituximab reduces risk of follicular lymphoma transformationJuly 25, 2018Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology TimesFDA approves biosimilar filgrastimJuly 22, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationAMLALL
Hematology TimesDiabetics have higher risk of hematologic, other cancersJuly 20, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology NewsAdding elotuzumab improves myeloma PFS over pom/dex aloneJuly 18, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesPET-guided treatment didn’t improve outcomesJuly 16, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology TimesMutations linked to higher risk of SNs in CCSsJuly 16, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
CAR T Therapy: From Bench to Bedside and BackJuly 15, 2018AnemiaLeukemia, Myelodysplasia, TransplantationALLAMLCellular TherapyLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsNew guideline for managing MCLJuly 13, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsPromising phase 3 results for ixazomib in multiple myelomaJuly 13, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsIbrutinib/venetoclax shows early promise in relapsed CLLJuly 11, 2018CLLAggressive LymphomasLymphoma & Plasma Cell Disorders
